JERRY COHEN: Open Payments
NPI 1629015680 · NARBERTH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 17 payments from 12 companies in 2025. Trend: 2023 $216 · 2024 $162 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| SK Life Science, Inc. | 2 | $37 |
| ARGENX US, INC. | 1 | $25 |
| Lundbeck LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| ACADIA Pharmaceuticals Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
Products named: REXULTI, INGREZZA, VYVGART HYTRULO, KISUNLA, COBENFY, NUPLAZID, GVOKE HYPOPEN, XIFAXAN.
Industry payments across PA — which companies pay providers there.
